bullishMay 6
Adjusted EBITDA margin expanded to 17.6% due to cost optimization and mix shift.
bearishMay 6
Total revenue declined 13.7% year-over-year, driven by a 41% drop in product sales.
bullishMay 6
Used IPO proceeds to retire $137 million in high-interest shareholder loans.
bullishMay 6
Completed IPO and over-allotment exercise, raising over $210 million in net proceeds.
bullishMay 6
Adjusted EBITDA margin expanded to 17.6% due to cost optimization and mix shift.
bearishMay 6
Total revenue declined 13.7% year-over-year, driven by a 41% drop in product sales.
bullishMay 6
Used IPO proceeds to retire $137 million in high-interest shareholder loans.
bullishMay 6
Completed IPO and over-allotment exercise, raising over $210 million in net proceeds.
bullishMay 6
Adjusted EBITDA margin expanded to 17.6% due to cost optimization and mix shift.
bearishMay 6
Total revenue declined 13.7% year-over-year, driven by a 41% drop in product sales.
bullishMay 6
Used IPO proceeds to retire $137 million in high-interest shareholder loans.
bullishMay 6
Completed IPO and over-allotment exercise, raising over $210 million in net proceeds.
bullishMay 6
Adjusted EBITDA margin expanded to 17.6% due to cost optimization and mix shift.
bearishMay 6
Total revenue declined 13.7% year-over-year, driven by a 41% drop in product sales.
bullishMay 6
Used IPO proceeds to retire $137 million in high-interest shareholder loans.
bullishMay 6
Completed IPO and over-allotment exercise, raising over $210 million in net proceeds.
bullishMay 6
Adjusted EBITDA margin expanded to 17.6% due to cost optimization and mix shift.
bearishMay 6
Total revenue declined 13.7% year-over-year, driven by a 41% drop in product sales.
bullishMay 6
Used IPO proceeds to retire $137 million in high-interest shareholder loans.
bullishMay 6
Completed IPO and over-allotment exercise, raising over $210 million in net proceeds.
bullishMay 6
Adjusted EBITDA margin expanded to 17.6% due to cost optimization and mix shift.
bearishMay 6
Total revenue declined 13.7% year-over-year, driven by a 41% drop in product sales.
bullishMay 6
Used IPO proceeds to retire $137 million in high-interest shareholder loans.
bullishMay 6
Completed IPO and over-allotment exercise, raising over $210 million in net proceeds.
bullishMay 6
Adjusted EBITDA margin expanded to 17.6% due to cost optimization and mix shift.
bearishMay 6
Total revenue declined 13.7% year-over-year, driven by a 41% drop in product sales.
bullishMay 6
Used IPO proceeds to retire $137 million in high-interest shareholder loans.
bullishMay 6
Completed IPO and over-allotment exercise, raising over $210 million in net proceeds.